Drugs / Pogejiuxin Decoction
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT06629246 Comparator | Sep 2021 → Aug 2023 | diastolic heart failure | Chongqing Traditional Chinese Medicine Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pogejiuxin Decoction | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06629246 ↗ |
| Route | Oral | “The intervention group will receive Pogejiuxin Decoction orally” NCT06629246 ↗ |